sepsis
FDA Clears Abionic Point-of-Care Sepsis Test
The rapid test is designed to measure blood levels of pancreatic stone protein, which is elevated in sepsis.
Accelerate Dx Gains FDA 510(k) Clearance for Blood Culture Sample Prep Platform
The Accelerate Arc System and BC kit are used for automated positive blood culture sample preparation for downstream microbial identification.
New England Hemolytics Gets $275K NSF Grant to Develop Pathogen DNA Extraction System
The company aims to test the system's ability to extract DNA from bacterial and fungal pathogens that cause sepsis.
Inflammatix Raises $57M in Series E Financing
The company said that it will use the money to support regulatory filings and commercialization of its 30-minute TriVerity Acute Infection and Sepsis Test.
Diagnostics firm QuantaMatrix plans to commercialize the technologies with an automated instrument for pathogen detection, identification, and resistance profiling.
Jun 27, 2024
Bluejay Diagnostics Prices $8.75M Public Offering
Mar 21, 2024